Literature DB >> 23606422

Patterns and mutational signatures of tandem base substitutions causing human inherited disease.

Jian-Min Chen1, Claude Férec, David N Cooper.   

Abstract

Tandem base substitutions (TBSs) are multiple mutations that comprise two or more contiguous nucleotide substitutions without any net gain or loss of bases. They have recently become recognized as a distinct category of human genomic variant. However, their role in causing human inherited disease so far has not been studied methodically. Here, using data from the Human Gene Mutation Database (http://www.hgmd.org), we identified 477 events to be TBSs (doublets, 448; triplets, 16; and quadruplets to octuplets, 13). A comprehensive sequence pattern and context analysis implied the likely fundamental importance of translesion synthesis (TLS) DNA polymerases in generating these diverse TBSs but revealed that TLS polymerases may operate differently in generating TBSs of ≤ 3 bases (bypass of endogenous DNA lesions) than those of ≥ 4 bases (serial replication slippage). Moreover, GC was found to be the most frequently affected dinucleotide with GC/GC>AA/TT being the most frequent double TBS. Comparison with cancer genome mutational spectra allowed us to conclude that human germline TBSs arise predominantly through the action of endogenous mechanisms of mutagenesis rather than through exposure to exogenous mutagens. Finally, the rates of double and triple TBSs were estimated to be 0.2-1.2 × 10(-10) and 0.8-4.8 × 10(-12) per base per generation, respectively.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  CpG transitions; cancer; hypermutability; serial replication slippage

Mesh:

Year:  2013        PMID: 23606422     DOI: 10.1002/humu.22341

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  11 in total

1.  Characterization of 26 deletion CNVs reveals the frequent occurrence of micro-mutations within the breakpoint-flanking regions and frequent repair of double-strand breaks by templated insertions derived from remote genomic regions.

Authors:  Ye Wang; Peiqiang Su; Bin Hu; Wenjuan Zhu; Qibin Li; Ping Yuan; Jiangchao Li; Xinyuan Guan; Fucheng Li; Xiangyi Jing; Ru Li; Yongling Zhang; Claude Férec; David N Cooper; Jun Wang; Dongsheng Huang; Jian-Min Chen; Yiming Wang
Journal:  Hum Genet       Date:  2015-03-20       Impact factor: 4.132

2.  Phenotypic expansion of visceral myopathy associated with ACTG2 tandem base substitution.

Authors:  Joakim Klar; Doroteya Raykova; Elisabet Gustafson; Iveta Tóthová; Adam Ameur; Alkwin Wanders; Niklas Dahl
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

3.  Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline.

Authors:  Eleni Giannoulatou; Gilean McVean; Indira B Taylor; Simon J McGowan; Geoffrey J Maher; Zamin Iqbal; Susanne P Pfeifer; Isaac Turner; Emma M M Burkitt Wright; Jennifer Shorto; Aysha Itani; Karen Turner; Lorna Gregory; David Buck; Ewa Rajpert-De Meyts; Leendert H J Looijenga; Bronwyn Kerr; Andrew O M Wilkie; Anne Goriely
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-20       Impact factor: 11.205

4.  Examining clustered somatic mutations with SigProfilerClusters.

Authors:  Erik N Bergstrom; Mousumy Kundu; Noura Tbeileh; Ludmil B Alexandrov
Journal:  Bioinformatics       Date:  2022-05-20       Impact factor: 6.931

5.  Biochemical and photochemical mechanisms that produce different UV-induced mutation spectra.

Authors:  Tomohiko Sugiyama; Brianna Keinard; Griffin Best; Mahima R Sanyal
Journal:  Mutat Res       Date:  2021-09-17       Impact factor: 3.151

6.  Three novel mutations of CHD7 gene in two turkish patients with charge syndrome; A double point mutation and an insertion.

Authors:  O Giray Bozkaya; E Ataman; C Randa; D Onur Cura; S Gürsoy; O Aksel; A Ulgenalp
Journal:  Balkan J Med Genet       Date:  2015-12-30       Impact factor: 0.519

7.  Codon-level co-occurrences of germline variants and somatic mutations in cancer are rare but often lead to incorrect variant annotation and underestimated impact prediction.

Authors:  Amanda Koire; Young Won Kim; Jarey Wang; Panagiotis Katsonis; Haijing Jin; Olivier Lichtarge
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

8.  Toward a clinical diagnostic pipeline for SPINK1 intronic variants.

Authors:  Xin-Ying Tang; Jin-Huan Lin; Wen-Bin Zou; Emmanuelle Masson; Arnaud Boulling; Shun-Jiang Deng; David N Cooper; Zhuan Liao; Claude Férec; Zhao-Shen Li; Jian-Min Chen
Journal:  Hum Genomics       Date:  2019-02-12       Impact factor: 4.639

9.  The repertoire of mutational signatures in human cancer.

Authors:  Ludmil B Alexandrov; Jaegil Kim; Gad Getz; Steven G Rozen; Michael R Stratton; Nicholas J Haradhvala; Mi Ni Huang; Alvin Wei Tian Ng; Yang Wu; Arnoud Boot; Kyle R Covington; Dmitry A Gordenin; Erik N Bergstrom; S M Ashiqul Islam; Nuria Lopez-Bigas; Leszek J Klimczak; John R McPherson; Sandro Morganella; Radhakrishnan Sabarinathan; David A Wheeler; Ville Mustonen
Journal:  Nature       Date:  2020-02-05       Impact factor: 49.962

10.  Clinical, neuroradiological and genetic findings in a cohort of patients with multiple Cerebral Cavernous Malformations.

Authors:  Silvia Lanfranconi; Lorenzo Piergallini; Dario Ronchi; Gloria Valcamonica; Giorgio Conte; Elena Marazzi; Giulia Manenti; Giulio Andrea Bertani; Marco Locatelli; Fabio Triulzi; Nereo Bresolin; Elisa Scola; Giacomo Pietro Comi
Journal:  Metab Brain Dis       Date:  2021-08-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.